Hormonal, Metabolic, and Signaling Interactions in PAH

Discovering Clinical Study Experiences of Patients With Pulmonary Hypertension

NCT05918458 ·Status: NOT_YET_RECRUITING

Genetic and Environmental Characteristics of Primary Pulmonary Hypertension

NCT00091546 ·Status: COMPLETED

Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study

NCT06753981 ·Status: RECRUITING

Trans-pulmonary Biomarkers in Pulmonary Hypertension

NCT01961232 ·Status: ACTIVE_NOT_RECRUITING

Pharmacogenomics in Pulmonary Arterial Hypertension

NCT00593905 ·Status: WITHDRAWN

Endothelial Cell Activation and Total Pulmonary Resistance in PAH

NCT06035861 ·Status: NOT_YET_RECRUITING ·Phase: NA

Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs

NCT03863990 ·Status: COMPLETED

The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.

NCT05908019 ·Status: UNKNOWN ·Phase: NA

Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension

NCT03554291 ·Status: COMPLETED ·Phase: PHASE2

Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension

NCT02080533 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH

NCT03841344 ·Status: UNKNOWN ·Phase: NA

Metabolic Remodeling in Pulmonary Arterial Hypertension (PAH)

NCT04968210 ·Status: COMPLETED

Novel Index (PIMR) in PAH

NCT05812976 ·Status: COMPLETED

Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension

NCT03528902 ·Status: COMPLETED ·Phase: PHASE2

Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients

NCT02551653 ·Status: COMPLETED ·Phase: PHASE1

129 Xenon Imaging in Patients Treated With Sotatercept

NCT06351345 ·Status: RECRUITING ·Phase: PHASE2

CXA-10 Study in Subjects With Pulmonary Arterial Hypertension

NCT04053543 ·Status: TERMINATED ·Phase: PHASE2

The PAH Platform for Deep Phenotyping in Korean Subjects

NCT03933579 ·Status: UNKNOWN

miRNA and Myokines in Patients With PAH

NCT03905083 ·Status: WITHDRAWN ·Phase: NA

Biomarkers in the Diagnosis and Assessment of Pulmonary Arterial Hypertension (PAH)

NCT00566423 ·Status: COMPLETED ·Phase: NA

Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis

NCT00567437 ·Status: TERMINATED ·Phase: NA

Prospective Longitudinal Study of Patients With Idiopathic Pulmonary Arterial Hypertension, Family or Taking Anorectics

NCT01185730 ·Status: COMPLETED ·Phase: NA

Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension

NCT00675051 ·Status: COMPLETED

The Expression and Significance of MiRNA

NCT00806312 ·Status: COMPLETED

Open-label, Multi-center Protocol to Provide QTI571 to PAH Patients Who Participated in the Extension Study (A2301E1) in Japan

NCT02042014 ·Status: COMPLETED ·Phase: PHASE3